“Treatment of patients with unresectable liver metastases


“Treatment of patients with unresectable liver metastases is challenging. Regional therapies to the liver have been developed that maximize treatment of the localized disease process without systemic toxic adverse effects. We discuss the procedural aspects of liver chemosaturation with percutaneous hepatic perfusion (CS-PHP).\n\nWe present as an illustration of this technique a case report of the treatment of unresectable metastatic leiomyosarcoma of the liver.\n\nA randomized phase ML323 manufacturer III trial for unresectable liver metastases from melanoma was recently completed comparing CS-PHP with melphalan vs.

best alternative care (BAC). When compared with BAC, CS-PHP was associated with a significant improvement in hepatic progression-free survival (8.0 months CS-PHP vs. 1.6 months BAC, p < 0.0001) and overall progression-free survival (6.7 months CS-PHP vs. 1.6 months BAC, p < 0.0001), respectively. On the basis of these results, and given

our experience as one of the treating institutions for this phase III trial, we appealed for compassionate use of CS-PHP in a patient with check details isolated bilobar unresectable hepatic metastases from leiomyosarcoma. Four target lesions were identified and monitored to assess treatment response. A total of 4 CS-PHP procedures were performed, with a 25 % reduction in size of the largest lesion observed Microtubule Associat inhibitor and 16 month hepatic progression-free survival. Toxicity was mild (neutropenia) and manageable on an outpatient basis.\n\nCS-PHP offers several advantages for unresectable hepatic sarcoma metastases. CS-PHP is minimally invasive and repeatable, and it has a predictable and manageable systemic toxicity profile. For appropriately selected patients, CS-PHP can delay tumor progression and could potentially improve survival.”
“While charge-ordering transition is well established in the oxygen-deficient layered cobaltite YBaCo2O5, there has been no evidence for the transition in the analogous compound GdBaCo2O5 either from neutron diffraction or from magnetic susceptibility

experiments. In this paper, we present comparative studies on the electron spin resonance (ESR) of Gd3+ ions in Y1-xGdxBaCo2O5 (x = 0.01, 0.25, and 1) polycrystalline samples. Magnetic susceptibility was also performed for comparison with the ESR results. It was found that charge-ordering transition for Y0.75Gd0.25BaCo2O5 revealed by the susceptibility is also manifested in the characters of the ESR data. The similar temperature-evolution of the ESR parameters for GdBaCo2O5 provides a support for the existence of charge-ordering transition, although no characteristic of the transition is evidenced from susceptibility experiments, which can be understood as being hidden by dominant paramagnetism of Gd3+ ions in this compound.

Comments are closed.